New oral agent for PCP is effective, well tolerated.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000284:Administration, Oral; D000981:Antiprotozoal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D053626:Atovaquone; D006801:Humans; D009285:Naphthoquinones / Q000008:administration & dosage* / Q000009:adverse effects; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D053626:Atovaquone